Syndrome/aetiology | Number | Per cent |
---|---|---|
Gastrointestinal syndromes | 44 | 29 |
Traveller’s diarrhoea, no confirmed aetiology | 27 | 17.5 |
Campylobacter | 3 | 2 |
Salmonella, non-typhoidal | 3 | 2 |
Salmonella typhi/enteric fever | 3 | 2 |
Strongyloidiasis | 2 | 1 |
Giardiasis | 1 | 0.6 |
Dientamoeba fragilis | 1 | 0.6 |
Viral enteritis | 1 | 0.6 |
Gastritis | 1 | 0.6 |
Clostridium difficile colitis | 1 | 0.6 |
Postinfectious irritable bowel syndrome | 1 | 0.6 |
Respiratory syndromes | 39 | 25 |
Viral upper respiratory tract infection | 11 | 7 |
Lobar pneumonia | 8 | 5 |
Influenza-like illness | 4 | 3 |
Influenza A | 4 | 3 |
Influenza B | 4 | 3 |
Mononucleosis and mono-like syndrome due to EBV or CMV | 3 | 2 |
Lower respiratory tract infection, non-lobar pneumonia | 1 | 0.6 |
Haemophilus influenzae | 1 | 0.6 |
Group A streptococcus pharyngitis | 1 | 0.6 |
Acute sinusitis | 1 | 0.6 |
Coxsackie virus | 1 | 0.6 |
Vector-borne, non-localising | 32 | 21 |
Dengue fever | 12 | 8 |
Chikungunya fever | 10 | 6.5 |
Rickettsioses | 6 | 4 |
Malaria, Plasmodium vivax | 2 | 1 |
Malaria, Plasmodium falciparum | 2 | 1 |
STI/genitourinary | 13 | 8 |
Acute urinary tract infection, including urosepsis | 7 | 4.5 |
Acute HSV-1 | 2 | 1 |
Acute HIV | 2 | 1 |
Syphilis, secondary | 1 | 0.6 |
Chlamydia trachomatis | 1 | 0.6 |
Fever with lymphadenopathy | 2 | 1 |
Lymphadenitis, bacterial | 1 | 0.6 |
Toxoplasmosis | 1 | 0.6 |
Skin and soft-tissue infections | 2 | 1 |
Cellulitis | 1 | 0.6 |
Shingles | 1 | 0.6 |
Musculoskeletal | 1 | 0.6 |
Septic arthritis | 1 | 0.6 |
Non-specific viral syndrome | 19 | 12 |
Non-infectious | 3 | 2 |
Temporal arteritis | 1 | 0.6 |
Toxidrome, cocaine | 1 | 0.6 |
Syncope | 1 | 0.6 |
No diagnosis | 3 | 2 |
CMV, cytomegalovirus; EBV, Epstein-Barr virus; HSV-1, herpes simplex virus type 1; RAFT, Rapid Assessment of Febrile Travelers; STI, sexually transmitted infection.